For instance, in Alzheimer’s disease, variations in the APOE gene are associated with differences in response to certain drugs, such as cholinesterase inhibitors, which are commonly prescribed to slow cognitive decline (Ray et al., 2011). This evidence concerns the gene BCHE and Alzheimer disease.